FT. MYERS, Fla., Feb. 11 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference in Dana Point, California. The date, time and location of the Company's presentation at the conference are as follows:
Date: Monday, February 16, 2009 Time: 4:20 PM Pacific Time Venue: The Ritz Carlton Laguna Niguel One Ritz-Carlton Drive Dana Point, California 92629
Webcast Link: http://www.wsw.com/webcast/roth20/ngnm/
The Roth 21st Annual OC Growth Stock Conference will feature presentations from over 200 growth companies. This event is designed to provide investors with a unique opportunity to gain insight into leading companies across all sectors. Additionally, there will be a special track dedicated to microcap companies. A live audio webcast of the presentation can be accessed at http://www.wsw.com/webcast/roth20/ngnm/. A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at http://www.neogenomics.org at the time of the conference. The webcast will be available for three months. Interested parties and investors may also find more information about the conference by contacting email@example.com or calling (800) 933-6830.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.
Interested parties can also access additional investor relations material from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates at http://www.hawkassociates.com. An investment profile about NeoGenomics may be found at www.hawkassociates.com/profile/ngnm.cfm .
Roth is a full service investment banking firm dedicated to the small and micro-cap market. Since the inception of the firm in 1984, Roth has been a leader and innovator in the small and micro cap markets. Roth's exclusive focus has been, is, and will continue to offer a full spectrum of investment banking services, including raising capital, research coverage, trading and market making, merger and acquisition advisory services, and investor conferences.
|SOURCE NeoGenomics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved